Core Scientific (NASDAQ:CORZ) Stock Price Up 2.2% After Analyst Upgrade

Core Scientific, Inc. (NASDAQ:CORZGet Free Report) traded up 2.2% on Friday after BTIG Research raised their price target on the stock from $8.00 to $10.00. BTIG Research currently has a buy rating on the stock. Core Scientific traded as high as $8.06 and last traded at $8.02. 866,347 shares traded hands during mid-day trading, a decline of 81% from the average session volume of 4,634,254 shares. The stock had previously closed at $7.85.

Separately, HC Wainwright reissued a “buy” rating and set a $5.00 price objective on shares of Core Scientific in a research note on Wednesday, March 13th.

Get Our Latest Stock Analysis on Core Scientific

Insider Buying and Selling

In related news, Director Eric Stanton Weiss bought 15,000 shares of the stock in a transaction dated Friday, March 15th. The shares were purchased at an average price of $3.03 per share, with a total value of $45,450.00. Following the completion of the acquisition, the director now owns 15,000 shares of the company’s stock, valued at $45,450. The purchase was disclosed in a filing with the SEC, which is available through this hyperlink. In related news, CEO Adam Taylor Sullivan acquired 65,300 shares of the firm’s stock in a transaction on Friday, March 15th. The shares were acquired at an average cost of $3.06 per share, for a total transaction of $199,818.00. Following the completion of the transaction, the chief executive officer now directly owns 93,753 shares in the company, valued at approximately $286,884.18. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Eric Stanton Weiss bought 15,000 shares of the company’s stock in a transaction dated Friday, March 15th. The stock was bought at an average price of $3.03 per share, with a total value of $45,450.00. Following the acquisition, the director now owns 15,000 shares in the company, valued at approximately $45,450. The disclosure for this purchase can be found here. 32.00% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the company. Aspect Partners LLC purchased a new position in shares of Core Scientific during the first quarter valued at approximately $29,000. Hexagon Capital Partners LLC purchased a new position in Core Scientific during the 1st quarter valued at $34,000. Lindbrook Capital LLC bought a new position in Core Scientific in the 1st quarter valued at $65,000. Fiduciary Alliance LLC purchased a new stake in Core Scientific in the first quarter worth $84,000. Finally, Dorsey & Whitney Trust CO LLC bought a new stake in shares of Core Scientific during the first quarter worth $122,000.

Core Scientific Stock Performance

The stock’s 50 day moving average price is $3.93 and its 200-day moving average price is $2.86.

Core Scientific (NASDAQ:CORZGet Free Report) last issued its earnings results on Wednesday, May 8th. The company reported $0.19 EPS for the quarter, topping analysts’ consensus estimates of $0.05 by $0.14. The company had revenue of $179.29 million during the quarter, compared to the consensus estimate of $139.60 million. As a group, sell-side analysts predict that Core Scientific, Inc. will post -0.17 EPS for the current fiscal year.

Core Scientific Company Profile

(Get Free Report)

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.

Featured Articles

Receive News & Ratings for Core Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Scientific and related companies with MarketBeat.com's FREE daily email newsletter.